/
partner with:

antibodies

number of breaks: 6

showing 1-5 of 6 breaks

Low and Mighty: How Low-Affinity Antibodies Boost Cancer Immunotherapy

Our body is constantly guarded by our immune system, which defends us from external threats like viruses and bacteria, and even internal rogue cells that can become cancerous. Antibodies, which are special proteins in our bodies, play a key role in this defence. They work... click to read more

  • Christian Orr | Beamline Scientist at Diamond Light Source
  • Chelsea Norman | Senior Laboratory Technician at Rosalind Franklin Institute
  • Mark Cragg | Professor at University of Southampton
Views 310
Reading time 4 min
published on Sep 8, 2023
The needle-free detection of SARS-CoV-2-specific antibodies from urine

While serological tests are not intended to diagnose an acute SARS-CoV-2 (COVID-19) infection, they can indicate the presence of antibodies generated from previous viral exposure or vaccination. Several diagnostic kits to assess the presence of SARS-CoV-2 antibodies are available on the market, all using blood/serum... click to read more

  • Fernanda Fonseca Ramos | Junior Postdoctoral Research Fellow at Universidade Federal de Minas Gerais, Belo Horizonte, Brazil
  • Eduardo Antônio Ferraz Coelho | Full Professor at Universidade Federal de Minas Gerais, Belo Horizonte, Brazil
  • Fernanda Ludolf | Senior Postdoctoral Research Fellow at Universidade Federal de Minas Gerais, Belo Horizonte, Brazil
Views 981
Reading time 3 min
published on Dec 22, 2022
Mild or severe COVID-19? An antibody story

At this point, we're no strangers to COVID-19, the disease caused by the viral agent SARS-CoV-2. Why some people got very sick with COVID-19, even die, while others had an only mild illness, barely even noticing they are sick, was an enigma even as the... click to read more

  • Arjun Arkal Rao | Data Scientist at ImmunoX initiative, UCSF COMET Consortium, UCSF CoLab University of California San Francisco San Francisco, USA
  • Alexis J. Combes | Group Leader at ImmunoX initiative, UCSF COMET Consortium, UCSF CoLab University of California San Francisco San Francisco, USA
Views 2927
Reading time 3.5 min
published on Aug 30, 2021
From days to hours: detecting SARS-CoV-2 neutralizing antibodies

Coronavirus Disease 2019 (COVID-19) requires no introduction. Since late December 2019, SARS-CoV-2, the virus that causes COVID-19, has infected close to 40 million and claimed over a million lives. Like in any other infection, the body mounts an immune response against SARS-CoV-2. One type of... click to read more

  • Charles Kevin Tiu | MD-PhD Student at Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore
  • Vivian Chih-Wei Chen | MD-PhD Student at Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore
Views 2840
Reading time 4 min
published on Jun 14, 2021
The Janus-Faced Nature of Cancer Immunity

Cancer, viruses, bacteria, and chemicals are threatening our bodies every day. The weapon our body uses to fight these threats is our immune system. When triggered by the presence of something it perceives as foreign (and therefore danger), our immune system will produce antibodies targeting... click to read more

  • Chih-Wei Lin | Staff Scientist at The Scripps research institute, San Diego, California, USA
  • Richard Lerner | Professor at The Scripps research institute, San Diego, California, USA
Views 3588
Reading time 3.5 min
published on Sep 21, 2020